OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
WCHG58

WCHG.DE

Specialty ChemicalsVerified

WCHG.DE has a liquidity position characterized by a current ratio of 3.06, indicating a strong ability to meet short-term obligations, but its free cash flow is negative at -980.2 million EUR, suggesting operational cash generation is insufficient to cover capital expenditures. The company's debt-to-equity ratio is 0.65, which is relatively moderate, but its net income is negative at -821.1 million EUR, reflecting significant financial distress. The company's profitability metrics are underperforming compared to industry standards. Its return on equity is -22.81%, and return on assets is -9.81%, both indicating poor capital efficiency and asset utilization. These figures are well below the typical performance of firms in the specialty chemicals industry, which usually maintain positive returns on equity and assets. WCHG.DE's revenue is primarily concentrated in a few segments, with no detailed breakdown provided in the available data. However, the company's geographic exposure is not specified, making it difficult to assess regional risk or growth potential. The lack of segment-specific data limits the ability to evaluate the performance of individual business lines or geographic regions. The company's growth trajectory is concerning, with a net loss of 821.1 million EUR and a negative operating income of 509.4 million EUR. Analysts have provided a mean price target of 82.50 EUR and a median price target of 87.00 EUR, but the majority of recommendations are "hold," indicating limited confidence in near-term recovery. The company's capital expenditures of 553.2 million EUR have not translated into positive cash flow, further complicating its growth prospects. The risk assessment for WCHG.DE highlights medium liquidity risk and low dilution risk. However, the company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities. The absence of significant dilution risk is a positive factor, but the company's financial performance remains a major concern. Recent events, including the latest financial filings, show a deteriorating financial position with declining profitability and negative cash flows. The company has not disclosed any major strategic initiatives or cost-cutting measures in the available data, which may be necessary to address its financial challenges.

30-day price · WCHG+6.20 (+6.7%)
Low$88.45High$104.70Close$99.30As of29 May, 00:00 UTC
Profile
CompanyWCHG.DE
TickerWCHG.DE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. WCHG.DE operates in the specialty chemicals industry, producing and selling chemical products for industrial and consumer applications.

Classification. WCHG.DE is classified in the Basic Materials economic sector under the Chemicals business sector with a confidence level of 0.92.

WCHG.DE has a liquidity position characterized by a current ratio of 3.06, indicating a strong ability to meet short-term obligations, but its free cash flow is negative at -980.2 million EUR, suggesting operational cash generation is insufficient to cover capital expenditures. The company's debt-to-equity ratio is 0.65, which is relatively moderate, but its net income is negative at -821.1 million EUR, reflecting significant financial distress. The company's profitability metrics are underperforming compared to industry standards. Its return on equity is -22.81%, and return on assets is -9.81%, both indicating poor capital efficiency and asset utilization. These figures are well below the typical performance of firms in the specialty chemicals industry, which usually maintain positive returns on equity and assets. WCHG.DE's revenue is primarily concentrated in a few segments, with no detailed breakdown provided in the available data. However, the company's geographic exposure is not specified, making it difficult to assess regional risk or growth potential. The lack of segment-specific data limits the ability to evaluate the performance of individual business lines or geographic regions. The company's growth trajectory is concerning, with a net loss of 821.1 million EUR and a negative operating income of 509.4 million EUR. Analysts have provided a mean price target of 82.50 EUR and a median price target of 87.00 EUR, but the majority of recommendations are "hold," indicating limited confidence in near-term recovery. The company's capital expenditures of 553.2 million EUR have not translated into positive cash flow, further complicating its growth prospects. The risk assessment for WCHG.DE highlights medium liquidity risk and low dilution risk. However, the company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities. The absence of significant dilution risk is a positive factor, but the company's financial performance remains a major concern. Recent events, including the latest financial filings, show a deteriorating financial position with declining profitability and negative cash flows. The company has not disclosed any major strategic initiatives or cost-cutting measures in the available data, which may be necessary to address its financial challenges.
Key takeaways
  • WCHG.DE is experiencing significant financial distress with a net loss of 821.1 million EUR and negative operating income.
  • The company's liquidity position is strong in terms of the current ratio, but its free cash flow is negative, indicating operational inefficiencies.
  • Profitability metrics such as return on equity and return on assets are well below industry norms, suggesting poor capital efficiency.
  • Analysts have issued a mixed outlook, with a mean price target of 82.50 EUR and a median price target of 87.00 EUR, but most recommendations are "hold."
  • The company's financial performance and negative cash flows raise concerns about its ability to sustain operations and invest in growth.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$5.49B
Gross profit$747.5M
Operating income-$509.4M
Net income-$821.1M
R&D
SG&A
D&A
SBC
Operating cash flow$542.6M
CapEx-$553.2M
Free cash flow-$980.2M
Total assets$8.37B
Total liabilities$4.77B
Total equity$3.60B
Cash & equivalents$637.3M
Long-term debt$2.35B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.60B
Net cash-$1.72B
Current ratio3.1
Debt/Equity0.7
ROA-9.8%
ROE-22.8%
Cash conversion-66.0%
CapEx/Revenue-10.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricWCHGActivity
Op margin-9.3%8.0% medp25 -2.2% · p75 23.4%bottom quartile
Net margin-15.0%5.5% medp25 -3.8% · p75 18.5%bottom quartile
Gross margin13.6%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-10.1%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity65.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target82.50 EUR
Median price target87.00 EUR
High price target110.00 EUR
Low price target50.00 EUR
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count3.00
Hold count11.00
Sell count3.00
Strong-sell count1.00
Mean EPS estimate0.46 EUR
Last actual EPS-18.58 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 21:33 UTC#ee426d6b
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 00:19 UTCJob: 82c5a529